Off-Label Promotion Versus “Not on the Label”

It continues to become increasingly more difficult for pharmaceutical companies to use field-based representatives ...

Physicians Reveal Their Preference for the Next President and Healthcare Policy Changes

Yes, this article will be touching on the upcoming presidential election, but don’t worry. ...

The Personalization of Anticancer Treatment: Implications for Pharma Marketers

The past five years have seen a breathtaking pace of innovation in the oncology ...

Are Pharmaceutical Reps Really Ancient History?

As many in pharma know, many doctors no longer welcome pharmaceutical reps in their ...

So You’re Saying There’s a Chance…

Lloyd Christmas: What do you think the chances are of a guy like you ...

Not All Doctors Hate DTC TV Ads

Back in November, the American Medical Association (AMA), the largest association of physicians in ...

How Does a Physician’s Practice Type Affect a Marketer’s Approach?

CMI/Compas’ annual Media Vitals report examines what physicians want from pharma, including a closer ...

We May Have Hep C Cures—But Do Patients Know?

Since the release of new therapies for Hepatitis C in the past two years, ...

The Identifiable Victim Effect

At the heart of our efforts to get patients to use their medication is ...

Rise in Prior Authorizations Puts Doctors Off Brands

For many years, insurers have used prior authorizations for prescription medications. When formulary tiers ...

Is Inclusive Geo-Fencing the Future of Point of Care?

In healthcare marketing circles, Geo-Fencing is a current buzzword. A geo-fence is a “virtual ...

Who’s Accountable for Adherence?

Some years ago, my whole approach to treating patients changed after a research colleague ...